NYSE$YCBD
cbdMD Inc · Q4 2025 earnings
Q4 2025 earnings · · After market close · Investor relations
Briefing
cbdMD reported Q4 2025, revenue of $5M, net loss of $283K.
For Q4 2025, cbdMD reported revenue of $5M, a net loss of $283K. Management discusses segment performance, capital allocation, and outlook in the earnings filing.
- Revenue $5M.
- Net loss $283K.
- cbdMD highlights liquidity, operations, and 2026 priorities.
Headline financials
Revenue & EPS history
cbdMD · Revenue · Quarterly
$5.02M
Revenue by segment
cbdMD · $3.8M total across 1 segment · Q2 2026
- E-commerce sales$3.8M—100.0%
Forward guidance
The release discusses cbdMD's outlook for upcoming periods, including capital allocation, operating priorities, and market risks, without relying solely on numeric EPS bridges.
Tailwinds
- cbdMD cites operational execution and demand trends supporting the outlook.
- Balance sheet and liquidity actions aim to fund growth and returns.
Headwinds
- GAAP profitability remained under pressure in Q4 2025.
- Macro, pricing, and input-cost volatility could pressure margins.
- Segment mix and one-time items may affect quarter-to-quarter comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
-0.5%
Avg return
Earnings day
-3.1%
Avg return
5 days after
-10.8%
Avg return
30 days after
42%
15 / 36 earnings
Positive
+70.1%
Q2 2020
Best reaction
-22.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +0.0% | +5.3% | -38.9% | |
| Q3 2025 | -11.1% | -22.4% | -20.0% | |
| Q2 2026 | -4.0% | -8.2% | -13.2% | |
| Q2 2025 | -4.0% | -8.2% | -13.2% | |
| Q1 2025 | -15.1% | -24.6% | -52.6% | |
| Q4 2024 | -15.7% | -22.1% | +14.4% | |
| Q3 2024 | +3.7% | +2.1% | +7.6% | |
| Q2 2024 | +0.0% | +1.0% | -8.6% | |
| Q1 2024 | -12.3% | -5.5% | -0.7% | |
| Q4 2023 | +7.9% | +6.4% | +17.7% | |
| Q3 2023 | +0.7% | -5.6% | -9.8% | |
| Q2 2023 | -6.9% | -6.0% | -21.6% | |
| Q1 2023 | -5.8% | +1.8% | -28.1% | |
| Q4 2022 | -22.4% | -29.9% | -8.6% | |
| Q3 2022 | -5.9% | -11.6% | -48.4% | |
| Q2 2022 | +8.4% | +28.6% | -31.7% | |
| Q1 2022 | -19.5% | -16.3% | -14.0% | |
| Q4 2021 | +3.5% | +0.9% | -7.1% | |
| Q3 2021 | -5.0% | -7.8% | +3.7% | |
| Q2 2021 | -21.8% | -17.4% | -0.3% | |
| Q1 2021 | +15.2% | -9.2% | -19.4% | |
| Q4 2020 | +15.1% | +6.5% | +6.5% | |
| Q3 2020 | +8.1% | +10.2% | -27.6% | |
| Q2 2020 | +70.1% | +71.1% | +54.6% | |
| Q1 2020 | +2.6% | +0.0% | -40.9% | |
| Q4 2019 | -0.7% | -1.4% | -59.7% | |
| Q3 2019 | -9.4% | -11.6% | -11.4% | |
| Q2 2019 | -3.1% | +0.6% | -2.0% | |
| Q1 2019 | +1.8% | +6.5% | -9.7% | |
| Q4 2018 | -12.4% | -21.1% | +7.2% | |
| Q3 2017 | +14.4% | +1.4% | +13.0% | |
| Q3 2018 | +14.4% | +1.4% | +13.0% | |
| Q2 2017 | -1.2% | -10.2% | -22.3% | |
| Q2 2018 | -1.2% | -10.2% | -22.3% | |
| Q1 2018 | -7.7% | -10.1% | -14.3% | |
| Q4 2017 | +2.9% | +5.3% | +18.6% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro